Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$42.84
0.621.47%
At close: Dec 11, 4:00 PM EST
$42.84
N/A
Pre-Market: 8:02 AM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Veracyte (VCYT) stock?
You can purchase shares of Veracyte (NASDAQ:VCYT) through any online brokerage.
Who are Veracyte (VCYT) competitors?
Other companies in Veracyte’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Legend Biotech Corp (NASDAQ:LEGN), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Centessa Pharmaceuticals PLC (NASDAQ:CNTA) and Ascentage Pharma Group International (NASDAQ:AAPG).
What is the forecast, or price target, for Veracyte (VCYT) stock?
Veracyte has a consensus price target of $44.00.
What is the current price for Veracyte (VCYT)?
The stock price for Veracyte (NASDAQ: VCYT) is $42.84 last updated December 12, 2025 at 4:00 PM EST.
Does Veracyte (VCYT) pay a dividend?
There are no upcoming dividends for Veracyte.
When is Veracyte (NASDAQ:VCYT) reporting earnings?
Veracyte does not have any upcoming earnings scheduled.
Is Veracyte (VCYT) going to split?
There is no upcoming split for Veracyte.
What sector and industry does Veracyte (VCYT) operate in?
Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
